Check out our most popular compounded medications! Get Started
The Montelukast Sodium 5.2 mg/ml Oral Liquid is a specially crafted medication designed for oral use, ensuring a precise and consistent dose of montelukast in each administration. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as children and the elderly. Montelukast is a leukotriene receptor antagonist that is commonly prescribed for the management of asthma and the relief of symptoms of allergic rhinitis. By providing montelukast in a liquid form, this medication simplifies the process of adjusting doses to meet individual patient needs and improves adherence to treatment regimens for these chronic conditions.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Montelukast Sodium is a leukotriene receptor antagonist that is commonly prescribed to manage and prevent symptoms of asthma and to relieve the symptoms of seasonal and perennial allergic rhinitis. The active ingredient, Montelukast Sodium, works by blocking substances in the body called leukotrienes, which are responsible for the inflammation, constriction of airways in the lungs, and the production of mucus in response to allergens. By inhibiting these leukotrienes, Montelukast Sodium effectively reduces bronchoconstriction, airway edema, and inflammation, leading to an improvement in breathing and a decrease in allergy symptoms.
The Montelukast Sodium 5.2 mg/ml Oral Liquid formulation is specifically designed to provide a precise dosage of the medication in a liquid form, which is particularly beneficial for patients who have difficulty swallowing tablets or capsules, such as children and the elderly. The liquid form allows for flexible dosing, which is essential for pediatric patients who require doses based on their weight. Additionally, the liquid formulation ensures that the medication can be administered accurately and consistently, which is critical for managing chronic conditions like asthma and allergic rhinitis.
For patients, it is important to understand that this medication is not intended for the immediate relief of acute asthma attacks. Instead, it should be used regularly to help control and prevent symptoms. Patients should follow the dosing instructions provided by their healthcare provider and use the medication as directed to achieve the best results. For prescribers, it is essential to tailor the dosage to the individual needs of the patient and to consider the convenience and compliance benefits of a liquid formulation when prescribing Montelukast Sodium.
If you have any questions about this Montelukast Sodium 5.2 mg/ml Oral Liquid formulation or its use in treating asthma and allergic rhinitis, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the safe and appropriate use of this medication.
Montelukast Sodium is a leukotriene receptor antagonist that is commonly used to manage symptoms of asthma and to relieve symptoms of seasonal allergies. When considering the use of Montelukast Sodium 5.2 mg/ml Oral Liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects.
Montelukast may interact with drugs that are metabolized by the cytochrome P450 system, particularly the CYP2C8 and CYP3A4 isoenzymes. Concurrent use with drugs that induce CYP2C8, such as rifampin, could potentially decrease the plasma concentration of montelukast, leading to reduced effectiveness. Conversely, inhibitors of CYP2C8, such as gemfibrozil, may increase the plasma levels of montelukast, potentially leading to an increase in side effects.
Additionally, caution should be exercised when montelukast is co-administered with other medications known to prolong the QT interval, as there is a theoretical risk of additive effects on the QT interval, although montelukast itself is not known to have any significant effects on the QTc interval.
Patients should also be advised to avoid taking aspirin or non-steroidal anti-inflammatory drugs (NSAIDs) if they have aspirin-sensitive asthma, as montelukast is often used to treat this condition. While montelukast can help control the symptoms of aspirin-sensitive asthma, concurrent use of aspirin or NSAIDs may trigger asthma attacks or other allergic reactions.
It is also important to consider the potential for drug interactions with over-the-counter (OTC) medications, herbal supplements, and vitamins. Patients should be encouraged to inform their healthcare provider of all medications and supplements they are taking to ensure safe use of montelukast oral liquid.
Montelukast oral liquid is used to treat asthma by reducing inflammation in the airways and preventing asthma attacks. For optimal management of these conditions, it is crucial to maintain consistent levels of the drug in the body, which can be affected by drug interactions.
Patients and prescribers should be aware that this is not an exhaustive list of all potential drug interactions. It is always recommended to consult with a healthcare provider or pharmacist before starting any new medications, including OTC drugs and supplements, while taking montelukast. If you have any questions or concerns regarding drug interactions with Montelukast Sodium 5.2 mg/ml Oral Liquid, please reach out to us at Bayview Pharmacy for further assistance.
Montelukast Sodium is a leukotriene receptor antagonist that works by blocking substances in the body called leukotrienes. Leukotrienes are
Montelukast Sodium Oral Liquid is prescribed to prevent and manage symptoms of asthma and to relieve symptoms of seasonal allergies, such as hay fever. It is also used to prevent exercise-induced bronchospasm. Its liquid form is conducive for patients who have difficulty swallowing tablets, particularly children and the elderly.
The medication should be taken orally, following the prescribed dosage by your healthcare provider. It is usually taken once daily, with or without food. For the liquid formulation, use the provided measuring device to ensure accurate dosing.
Yes, this liquid medication is often prescribed to pediatric patients who cannot swallow tablets or chewables. It allows for precise dosing adjusted to the child's weight and age. However, always consult with a pediatrician before administering this medication to a child.
The shelf life after opening can vary, so it is essential to refer to the pharmacy label or consult with the pharmacist for storage guidelines and expiration information. Typically, it should be used within a specified number of days or weeks after first opening.
It generally can be taken with or without food. However, for specific dietary instructions or restrictions like mixing with food or drinks, it is advisable to consult with your healthcare provider.
If you miss a dose, take it as soon as you remember. However, if it's almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for the missed one.
Like all medications, Montelukast Sodium Oral Liquid can cause side effects, although not everybody gets them. Common side effects can include abdominal pain, headache, and thirst. Severe side effects are rare, but can include mood changes or allergic reactions. You should contact your healthcare provider if you experience any unusual symptoms.
Montelukast may interact with other medications, so it's important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. They will advise you on any potential interactions.
Montelukast is not known to interfere with most lab tests, but it's always a good practice to inform your healthcare provider about all medications you are taking before undergoing any laboratory tests.
Store the medication at room temperature, away from direct light and moisture, and keep out of reach of children. Do not store in the bathroom or freezer unless specified by the compounding pharmacist or product label.
The safety of Montelukast Sodium Oral Liquid during pregnancy or breastfeeding has not been fully established. If you are pregnant or breastfeeding, consult your healthcare provider for advice before taking this medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
